期刊文献+

对甲磺酰基苯丙烯酸异羟肟酸和酰脲衍生物的合成及抗炎活性 被引量:2

Synthesis and anti-inflammatory activity of hydroxamic acid and acyl urea derivatives of p-(methanesulfonyl)phenylpropenoic acids
在线阅读 下载PDF
导出
摘要 目的研究对甲磺酰基苯丙烯酸的异羟肟酸和酰脲衍生物的合成及其抗炎活性。方法将对甲磺酰基苯丙烯酸转化成其异羟肟酸 (Ⅳ )和酰脲衍生物 (Ⅴ ) ,评价Ⅳ和Ⅴ的抗炎活性以及连续经口服给药对大鼠胃肠道的影响。结果合成了 10个新化合物 (Ⅳ1~Ⅳ5和Ⅴ1~Ⅴ5) ,其结构经IR、1H NMR和MS确证。小鼠试验表明 :Ⅳ1、Ⅳ4、Ⅳ5和Ⅴ1、Ⅴ3 、Ⅴ5的抗炎活性与双氯芬酸钠和罗非昔布相当 (P >0 0 5 ) ;大鼠试验显示 :Ⅴ3 和Ⅴ5的抗炎活性与双氯芬酸钠和罗非昔布相当 (P>0 0 5 ) ,Ⅳ4、Ⅴ3 和Ⅴ5的胃肠道损伤显著小于双氯芬酸钠 (P <0 0 1) ,与罗非昔布和CMC Na相当 (P >0 0 5 )。结论对甲磺酰基苯丙烯酸的异羟肟酸和酰脲衍生物抗炎活性较强 ,胃肠道不良反应小 ,值得深入研究。 Aim To study on synthesis and anti-in flammatory activity of hydroxamic acid and acyl urea derivatives of p-(me thanesulfonyl)phenylpropenoic acids.Method Some of p-(methanesu lfonyl)phenylpropenoic acids were converted to their hydroxamic acids( Ⅳ)and acyl ureas(Ⅴ).The anti-inf lammatory activities against xylene-induced m ic e ear swelling and carrageenan-induced rat paw edema of Ⅳ and Ⅴ were evaluate d,and the side effects of their gastrointestinal tracts(GI) in the rats were exa mined.Results Ten new compounds(Ⅳ 1~Ⅳ 5 and Ⅴ 1~Ⅴ 5)were obtained,and their s tructure s were determined by IR, 1H-NMR and MS.Six of them(Ⅳ 1, Ⅴ 4,Ⅴ 5 and Ⅴ 1,Ⅴ 3,Ⅴ 5)exhibited mark ed anti-inflammatory activity comparable with CMC-Na in xylene-induced m ice ear swelling model,and Ⅴ 3 and Ⅴ 5 showed remarkable anti-inflammatory activity c omparable with diclofenac sodium and selective COX-2 inhibitor rofecoxib in car rag eenan-induced rat paw edema model(P>0 05).Ⅳ 4 a nd Ⅴ 3 and Ⅴ 5 had less GI side effec ts than diclofenac sodium(P<0 01),and no significant difference compared w ith CMC-Na and rofecoxib(P>0 05).Conclusion Hydroxamic acid and acyl urea derivatives of p-(methanesulfonyl)phenylpropenoic acids possess h igh anti-inflammatory activity and less GI side effects than their parent acids .
出处 《中国药物化学杂志》 CAS CSCD 2004年第5期257-262,M003,共7页 Chinese Journal of Medicinal Chemistry
关键词 药物化学 制备 化学合成 对甲磺酰基苯丙烯酸 羟肟酸 酰脲 抗炎活性 胃肠道副作用 medicinal chemistry preparation chemical synthesis p-(methanesulfonyl)phenylpropenoic acids hydroxamic acid acyl urea anti-in flammatory activity gastrointestinal side effects
  • 相关文献

参考文献10

  • 1夏敏,陶嘉泳.乙醇对小鼠胃粘膜的损伤机制[J].新消化病学杂志,1997,5(4):211-212. 被引量:37
  • 2Bandarage UK,Chen LQ,Fang XQ,et al.Nitrosothiol esters of diclofenac:synthesis and pharmacological characterization as gastrointestinal-sparing prodrug[J].J Med Chem,2000,43(21):4005-4016.
  • 3Kneen G,Jackson WP,Islip PJ,et al.Preparation of arylhydroxamic acid derivative compositions containing them,and their use in medicane and other applications[P].EP:196184,1986-10-01.
  • 4Flynn DL,Capiris T,Cetenko WJ,et al.Nonsteroildal anti-inflammatory drug hydroxamic acids,dual 5-lipoxygenase and cyclooxygenase inhibitors[J].J Med Chem,1990,33(8):2070-2072.
  • 5Summers JB,Mazdiyasni H,Holms JB,et al.Hydroxamic acid inhibitors of 5-lipoxygenase[J].J Med Chem,1987,30(11):574-580.
  • 6Winter CA,Risley EA,Nuss GW.Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs[J].Proc Soc Exp Biol Med,1962,111(3):544-547.
  • 7van Arman CG,Begany AJ,Miller LM,et al.Some details of the inflammations caused by yeast and carrageenin(with appendix on kinetics of the reaction)[J].Pharmacol Exp Ther,1965,150(2):328-334.
  • 8敖桂珍,张奕华,季晖,邓钢,吴艳俊,彭司勋.α-取代的对甲磺酰基苯丙烯酸的合成及抗炎活性[J].中国药科大学学报,2002,33(6):460-465. 被引量:8
  • 9敖桂珍,张奕华,季晖,邓钢.α-取代的对甲磺酰基苯丙烯酰胺的合成及抗炎活性[J].药学学报,2003,38(9):671-676. 被引量:4
  • 10敖桂珍,张奕华,季晖,邓钢.一氧化氮供体型α-取代的对甲磺酰基苯丙烯酸酯的合成及抗炎活性[J].中国药科大学学报,2004,35(3):200-204. 被引量:3

二级参考文献11

共引文献44

同被引文献33

  • 1敖桂珍,张奕华,季晖,邓钢.一氧化氮供体型α-取代的对甲磺酰基苯丙烯酸酯的合成及抗炎活性[J].中国药科大学学报,2004,35(3):200-204. 被引量:3
  • 2FUNK C D. Prostaglandins and leukotIienes: advances in eicosanoid biology [ J]. Science,2001,294 (5548) : 1871-1875.
  • 3CHARLIER C, MICHAUX C. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs [ J ]. Eur J Med Chem ,2003,38:645-659.
  • 4DANNHARDT G, KIEFER W. Cyclooxygenase inhibitors - current status and future prospects [ J]. Eur J Med Chem,2001,36 (2) :109-126.
  • 5GAMBARO G. Strategies to safely interfere with prostanoid activity while avoiding adverse renal effects: could COX-2 and COX- LOX dual inhibition be the answer[ J]. Nephrol Dial Transplant, 2002,17 (7) :1159-1162.
  • 6PARENTE L. Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition:Is two better than one[ J]. J Rheumatol,2001,28 ( 11 ) :2375-2382.
  • 7MUKHERJEE D. Selective cyclooxygenase-2 ( COX-2 ) inhibitors and potential risk of cardiovascular events. [ J]. Biochem Pharmacol ,2002,63 (5) :817-821.
  • 8PARENTE L, PERRETTI M. Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight [ J ]. Biochem Pharmacol,2003,65 (2) : 153-159.
  • 9YOUNG R N. Inhibitors of 5-lipoxygenase:a therapeutic potential yet to be fully realized? [J]. Eur J Med Chem, 1999,34:671- 685.
  • 10LEHNIGK B,RABE K F,DENT G,et al. Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients[J]. Eur Respir J, 1998, 11 (3) :617-623.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部